Henri K. Parson, PhD
Director, Microvascular Lab
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Assistant Professor, Department of Internal Medicine

This e-mail address is being protected from spambots. You need JavaScript enabled to view it   (757) 446-7976

Dr. Henri Parson joined the EVMS Strelitz Diabetes Center in January of 2001. During her first year, she was extensively involved in the coordination of a clinical research study involving physical activity, in situ nitric oxide measurements and neurovascular dysfunction.

Subsequently, she was awarded a two-year American Diabetes Association (ADA) fellowship to continue performing research on the mechanistic defect in diabetic neuropathy. She has also presented her work at ADA scientific meetings and published the results in several peer-reviewed journals. Dr. Parson was promoted to Director of the Microvascular Biology Lab at the Strelitz Diabetes Center. Her mission is to make advances in diabetic neuropathy research by understanding the mechanistic defect in neurovascular dysfunction and the cultural and socioeconomic disparities that cause increased diabetic ulcerations and amputations in minority populations.

Selected Publications

• Morrison S, Colberg SR, Mariano M, Parson HK, Vinik AI. Balance training reduces falls risk in older individuals with type 2 diabetes. Diabetes Care. 2010 Jan 22. [Epub ahead of print].
• Parson HK, Bundy MA, Dublin CB, Boyd AL, Paulson JF, Vinik AI. Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 3:19-26, 2010.
• Colberg SR, Azoury KR, Parson HK, Vinik AI. Exercise status affects skin perfusion via prostaglandin, nitric oxide, and EDHF pathways in diabetes. Microvasc Res. 2009 Mar;77(2):120-4. Epub 2008 Dec 3.